About Novomix
Novomix is a company based in Mahape (India). It operates as a B2B. The company has 107 employees as of March 31, 2023. Novomix operates in a competitive market with competitors including Accent Microcell, Amster Microcell and NextGen Exsome, among others.
- Headquarter Mahape, India
- Employees 107 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Novo Excipients Private Limited
- Date of Incorporation 01 Oct, 2003
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$10.02 M (USD)66.15as on Mar 31, 2023
-
Net Profit
$842.38 K (USD)107.93as on Mar 31, 2023
-
EBITDA
$1.44 M (USD)37.67as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
107
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Novomix
Detailed funding history for Novomix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novomix
Investment portfolio details for Novomix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Novomix
Detailed financials for Novomix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novomix Comparisons
Peer comparison for Novomix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novomix
Novomix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accent Microcell, Amster Microcell and NextGen Exsome, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microcrystalline cellulose and excipients are manufactured by Accent Microcell.
|
|
| Locked | Locked | Locked |
Produces excipients like microcrystalline cellulose for pharmaceutical and nutraceutical industries.
|
|
| Locked | Locked | Locked |
Offers exosome engineering, analysis, and purification services for industrial sectors.
|
Detailed competitors of Novomix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novomix
Complete news archive for Novomix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novomix
Novomix is headquartered in Mahape, India. It is registered at Mahape, Maharashtra, India.
As of Mar 31, 2023, the latest employee count at Novomix is 107.
Annual revenue of Novomix is $10.02M as on Mar 31, 2023.
Novomix operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and excipients production. Develops and manufactures pharmaceutical excipients for industry applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Novomix's top competitors include Accent Microcell, Amster Microcell and NextGen Exsome.